ArticleHuman mutation2014

Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.

Daman Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.